Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database

Samawi, HH; Hao-Wen, S; Chan, K; Alghamdi, MA; Lee-Ying, RM; Knox, J; Gill, P; Romagnino, A; Batuyong, E; Ko, YJ; Cheung, WY; Tam, VC

ANNALS OF ONCOLOGY, 2017; 28 ( ):